Search Results - "SHAFRAN, S"

Live attenuated herpes zoster vaccine for HIV‐infected adults by Shafran, SD

“…Objectives Multiple guidelines exist for the use of live viral vaccines for measles‐mumps‐rubella (MMR), varicella and yellow fever in people with HIV…”
Get full text

BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response by Andrieu, Guillaume P., Shafran, Jordan S., Smith, Charlotte L., Belkina, Anna C., Casey, Allison N., Jafari, Naser, Denis, Gerald V.

“…Therapeutic strategies aiming to leverage anti-tumor immunity are being intensively investigated as they show promising results in cancer therapy. The…”
Get full text

BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK by Shafran, Jordan S, Andrieu, Guillaume P, Györffy, Balázs, Denis, Gerald V

“…The inevitable progression of advanced prostate cancer to castration resistance, and ultimately to lethal metastatic disease, depends on primary or acquired…”
Get full text

Response to Noe, Oldenbuettel and Jaeger by Shafran, SD, Di Perri, G

Get full text

More than agents: Federal bureaucrats as information suppliers in policymaking by Shafran, JoBeth S.

“…Bureaucrats are frequently conceptualized as agents of Congress, with much focus placed on their expertise as policy implementers or evaluators. That same…”
Get full text

Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamide by Shafran, SD, Di Perri, G, Esser, S, Lelièvre, J‐D, Parczewski, M

“…Since the introduction of suppressive antiretroviral therapy (ART), HIV has become a chronic disease, with infected people in high‐income countries approaching…”
Get full text

Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II‐III) by Shafran, S. D., Shaw, D., Charafeddine, M., Agarwal, K., Foster, G. R., Abunimeh, M., Pilot‐Matias, T., Pothacamury, R. K., Fu, B., Cohen, E., Cohen, D. E., Gane, E.

“…Summary The efficacy and safety of an investigational combination of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r) plus sofosbuvir (SOF) ± ribavirin (RBV) in…”
Get full text

The effect of low‐dose ritonavir monotherapy on fasting serum lipid concentrations by Shafran, SD, Mashinter, LD, Roberts, SE

“…Objectives Ritonavir (RTV) at doses of 400 mg twice a day (bid) or higher adversely affects serum lipids. However, the effect of RTV 100 mg bid on serum lipids…”
Get full text

New Architectures for Radio-Frequency DC-DC Power Conversion by Rivas, J.M., Wahby, R.S., Shafran, J.S., Perreault, D.J.

“…This document proposes two new architectures for switched-mode dc-dc power conversion. The proposed architectures enable dramatic increases in switching…”
Get full text

The multi-faceted dynamics of HIV-1 transmission in Northern Alberta: A combined analysis of virus genetic and public health data by Vrancken, B., Adachi, D., Benedet, M., Singh, A., Read, R., Shafran, S., Taylor, G.D., Simmonds, K., Sikora, C., Lemey, P., Charlton, C.L., Tang, J.W.

“…Molecular epidemiology has become a key tool for tracking infectious disease epidemics. Here, the spread of the most prevalent HIV-1 subtypes in Northern…”
Get full text

High Svr Rates with ABT-493 + ABT-530 Co-Administered for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 3 Infection by Muir, A.J, Strasser, S, Wang, S, Shafran, S, Bonacini, M, Kwo, P, Wyles, D, Gane, E, Lovell, S.S, Lin, C.-W, Ng, T.I, Kort, J, Mensa, F.J

Get full text

Infective Endocarditis: Review of 135 Cases over 9 Years by Sandre, Roger M., Shafran, Stephen D.

“…One hundred thirty-five cases of infective endocarditis in adults at the University of Alberta Hospital from 1985 to 1993 were reviewed and the von Reyn and…”
Get full text

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study) by Asselah, T, Shafran, S, Bourgeois, S, Lai, C.-L, Cramp, M, Mathurin, P, Willems, B, Nguyen, M.H, Davis, M.N, Huang, K.C, Svarovskaia, E, Osinusi, A, Mcnally, J, Brainard, D, McHutchison, J, Shaikh, O.S, Tran, T.T

Get full text

P1112 LONG TERM FOLLOW-UP OF PATIENTS TREATED WITH SOFOSBUVIR IN THE FISSION, POSITRON, FUSION AND NEUTRINO PHASE 3 STUDIES by Cheng, W, Shafran, S, Beavers, K, Mo, H, McNally, J, Brainard, D.M, Symonds, W.T, Chojkier, M, Mangia, A, Schwabe, C

Get full text

P0886 : Efficacy and safety of grazoprevir/elbasvir +/- RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-edge treatment-experienced trial by Kwo, P, Gane, E, Peng, C.-Y, Pearlman, B, Vireling, J, Serfaty, L, Buti, M, Shafran, S, Stryszak, P, Lin, L, Gress, J, Robertson, M, Wahl, J, Barr, E, Haber, B

Get full text

O059 : Long-term persistence of HCV NS5A variants after treatment with NS5A inhibitor ledipasvir by Dvory-Sobol, H, Wyles, D, Ouyang, W, Chodavarapu, K, McNally, J, Cheng, W, Shafran, S, Mangia, A, Schwabe, C, Miller, M.D, Mo, H

Get full text

Mycobacterium chimaera Infection After Aortic Valve Replacement Presenting With Aortic Dissection and Pseudoaneurysm by O'Neil, C R, Taylor, G, Smith, S, Joffe, A M, Antonation, K, Shafran, S, Kunimoto, D

“…We present a case of infection presenting with aortic dissection and pseudoaneuysm in a 22-year-old man with a past history of aortic valve replacement…”
Get full text

Ledipasvir/Sofosbuvir with Ribavirin for 12 Weeks is Effective and Safe in Treatment-Naïve Genotype-3 Hepatitis C-Infected Patients in Canada by Feld, J, Ramji, A, Shafran, S, Willems, B, Marotta, P, Huchet, E, Vachon, M.-L, Svarovskaia, E, Huang, K, Hyland, R, Yun, C, Brainard, D, McHutchison, J, Tam, E, Bailey, R, Cooper, C, Yoshida, E, Greenbloom, S, Elkhashab, M, Borgia, S, Swain, M

Get full text

Safety and Immunogenicity of Glycoprotein D—Adjuvant Genital Herpes Vaccine by Bernstein, David I., Aoki, Fred Y., Tyring, Stephen K., Stanberry, Lawrence R., Pierre, Claude St, Shafran, Stephen D., Roels, Geert Leroux, Van Herck, Koen, Bollaerts, Anne, Dubin, Gary

“…Background. Two previous trials have suggested that a herpes simplex virus (HSV) type 2 glycoprotein D (gD) vaccine combined with the adjuvants alum and…”
Get full text

Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial by Gorfinkel, I S, Aoki, F, McNeil, S, Dionne, M, Shafran, S D, Zickler, P, Halperin, S, Langley, J, Bellamy, A, Schulte, J, Heineman, T, Belshe, R

“…Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) infections continue to be among the most common and unrecognized sexually transmitted infections in the world…”
Get more information